1. Home
  2. QNST vs ESPR Comparison

QNST vs ESPR Comparison

Compare QNST & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuinStreet Inc.

QNST

QuinStreet Inc.

HOLD

Current Price

$13.10

Market Cap

694.8M

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

814.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNST
ESPR
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
694.8M
814.3M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
QNST
ESPR
Price
$13.10
$3.16
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$24.75
$8.75
AVG Volume (30 Days)
673.5K
9.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
1.07
N/A
Revenue
$282,140,000.00
$403,135,000.00
Revenue This Year
$18.59
N/A
Revenue Next Year
$14.80
$12.81
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
21.31
52 Week Low
$10.29
$0.95
52 Week High
$17.13
$4.18

Technical Indicators

Market Signals
Indicator
QNST
ESPR
Relative Strength Index (RSI) 60.95 69.27
Support Level $12.98 $3.11
Resistance Level $13.67 $3.18
Average True Range (ATR) 0.48 0.01
MACD 0.12 -0.02
Stochastic Oscillator 95.28 66.67

Price Performance

Historical Comparison
QNST
ESPR

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: